Literature DB >> 3224433

Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids.

C Klett1, W Hellmann, F Suzuki, S Nakanishi, H Ohkubo, D Ganten, E Hackenthal.   

Abstract

In isolated rat hepatocytes, exposed to angiotensin II and glucocorticoids, angiotensinogen mRNA increased within 30-60 min, and angiotensinogen secretion with a time lag of about 2 hours. After 4 hours, angiotensinogen mRNA, estimated by liquid hybridization with radiolabeled cRNA, was 5.9 +/- 0.4 in control, and 10.8 +/- 0.8, 11.7 +/- 0.4, 16.1 +/- 0.8 and 21.7 +/- 0.2 pg/micrograms of total RNA in cells exposed to angiotensin II (9 nM and 90 nM), hydrocortisone (100 microM) and dexamethasone (10 microM) respectively. The corresponding secretion rates of angiotensinogen were 72 +/- 7, 124 +/- 4, 132 +/- 12, 220 +/- 19 and 217 +/- 18 fmol angiotensinogen/mg wet weight/hour. Thus, angiotensin II stimulates angiotensinogen synthesis and secretion by acting at a pretranslational site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3224433     DOI: 10.1080/07300077.1988.11878797

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  7 in total

1.  Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.

Authors:  W R Huckle; C A Prokop; R C Dy; B Herman; S Earp
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter.

Authors:  K Tamura; S Umemura; M Ishii; K Tanimoto; K Murakami; A Fukamizu
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

3.  Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure in rats.

Authors:  M Finckh; W Hellmann; D Ganten; A Furtwängler; J Allgeier; M Boltz; J Holtz
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

4.  The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.

Authors:  O T Eipel; K Németh; D Török; K Csordás; M Hegyi; A Ponyi; A Ferenczy; D J Erdélyi; M Csóka; G T Kovács
Journal:  Int J Hematol       Date:  2013-01-26       Impact factor: 2.490

5.  Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure.

Authors:  H Schunkert; J R Ingelfinger; A T Hirsch; S S Tang; S E Litwin; C E Talsness; V J Dzau
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice.

Authors:  W M Clouston; I G Lyons; R I Richards
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

7.  Reciprocal change in angiotensinogen mRNA expression in rat myocardium and liver after myocardial infarction.

Authors:  H S Kim; B H Oh; K H Han; S I Oh; T J Youn; C H Kim; M M Lee; Y B Park; Y S Choi; Y W Lee
Journal:  Heart Vessels       Date:  1998       Impact factor: 1.814

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.